Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Venus Concept ( (VERO) ).
On October 31, 2025, Venus Concept Inc. and its subsidiaries entered into a Consent Agreement with Madryn Health Partners, providing relief under a prior loan agreement by waiving certain liquidity requirements and allowing interest payments to be applied to the principal balance. Additionally, they amended a bridge loan agreement to extend its maturity date and waive liquidity requirements until November 30, 2025. The company also completed a Thirteenth Delayed Drawdown on October 28, 2025, securing $2,000,000 for general working capital purposes.
The most recent analyst rating on (VERO) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Venus Concept stock, see the VERO Stock Forecast page.
Spark’s Take on VERO Stock
According to Spark, TipRanks’ AI Analyst, VERO is a Neutral.
Venus Concept’s overall stock score is primarily impacted by its poor financial performance, characterized by high leverage, declining revenues, and substantial losses. Technical analysis and valuation further reflect bearish sentiment and lack of profitability. While the earnings call highlights some strategic improvements, significant challenges remain, limiting the overall score.
To see Spark’s full report on VERO stock, click here.
More about Venus Concept
Average Trading Volume: 86,384
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.92M
For detailed information about VERO stock, go to TipRanks’ Stock Analysis page.